| April 30, 2025 |
11:30 |
Prof. Vincent Pernet, Associate professor of neuroscience at the University of Bern, Research group leader at the Center for experimental neurology (ZEN), department neurology of the Inselspital, Bern, Adjunct Professor at the department of molecular medicine of the University Laval, Quebec City, Canada. |
Antibody delivery strategies promoting neuronal plasticity in the central nervous system |
C. Bourquin |
Dec 05, 2024
|
16:00 |
Dr. Christian Hotz, Senior Director at BioNTech |
mRNA applications for cancer immuno therapy at BioNTech |
C. Bourquin |
Nov 27, 2024
|
12:00 |
Dr. Juan Zhang, Associate Director, Novartis Institutes for Biomedical Research, Basel |
The Interplay between Analytics and Biology for Biomedical Research |
V. van der Velpen |
| July 9, 2024 |
11:00 |
Dr. Collado Diaz Victor, Institute of Pharmaceutical Sciences, ETH Zurich |
Cardiovascular Toxicity in Chronic Therapies: The Role of P2X7 Receptors in Health and Disease |
G. Konstantinidou |
Mar 6, 2024
|
12:15 |
Prof. Dr. Pablo Sinues, University Children's Hospital Basel, University of Basel, Basel
|
Pharmacometabolomics guided by breath analysis |
V. van der Velpen |
Nov 15, 2023
|
12:15 |
Prof. Dr. med. Dagmar Meyer zu Heringdorf, Pharmazentrum Frankfurt, Frankfurt am Main |
News in cellular Ca2+ signalling by sphingosine 1-phosphate |
A. Huwiler
|
Nov 1, 2023
|
12:15 |
PD Dr. med. Tatiana Bremova-Ertl, Universitätsklinik für Neurologie, Inselspital, Bern |
N-Acetyl-L-Leucine: A symptomatic drug with neuroprotective potential? |
A. Huwiler
|
Oct 25, 2023
|
12:15 |
Prof. Dr. Özlem Tastan Bishop, Research Unit in Bioinformatics (RUBi), Department of Biochemistry and Microbiology, Rhodes University, Grahamstown/Makhanda, 6139, South Africa |
Proteins and missense mutations in health and disease |
C. Largiadèr
|
Oct 18, 2023
|
12:15 |
Prof. Dr. med. Pier Paolo Scaglioni, Division of Hematology Oncology, University of Cincinnati, USA |
Lipid metabolism regulates ferroptosis in lung cancer
|
G. Konstantinidou
|
Oct 11, 2023
|
12:15 |
PD Dr. med. Tatiana Bremova-Ertl, Universitätsklinik für Neurologie, Inselspital, Bern |
N-Acetyl-L-Leucine: A symptomatic drug with neuroprotective potential?
|
A. Huwiler
|
Sept 14, 2023
|
13:30 |
Prof. Matej Orešič, Örebro University, Sweden |
Metabolome and exposome in metabolic dysfunction associated steatotic liver disease. Place: Microscopy- lecture hall, Pathology |
M. Masoodi
|
June 22, 2023
|
12:15 |
Dr. Gergely Gyimesi, Department of Biomedical Research/Nephrology, University of Bern |
SLC Atlas: towards a unified view
|
A. Huwiler
|
Mar 15, 2023
|
12:15 |
Prof. Dr. Manuele Rebsamen, Department of Immunobiology, University of Lausanne |
Solute carriers in metabolism and (auto)immunity: molecular mechanisms and therapeutic potential |
G. Konstantinidou |
Mar 14, 2023
|
12:15 |
Prof. Dr. Andreas Strasser, The Walter and Eliza Hall Institute of Medical Research (WEHI), Melbourne, Australia |
How does the tumour suppressor p53 prevent the development of cancer? |
T. Kaufmann
|
Feb 28, 2023
|
14:00 |
Prof. Rami Aqeilan, Lautenberg Center for Immunology and Cancer Research, Hebrew University – Hadassah Medical School, Jerusalem, Israel |
Non-canonical roles for long and fragile genes in cancer and neuropathologies |
H-U Simon
|
Feb 1, 2023
|
12:15 |
PD Dr. Stephan Kellenberger, Department of Biomedical Sciences, University of Lausanne |
Cellular roles and molecular mechanisms of acid-sensing ion channels |
A. Huwiler
|
| Jan 18, 2023 |
12:15 |
Prof. Dr. Patrycja Nowak-Sliwinska, Institute of Pharmaceutical Sciences, University of Geneva |
Why one drug is not enough? |
G. Konstantinidou |
| Dec 19, 2022 |
12:15 |
Dr. Anna Brichkina, Center for Tumor Biology and Immunology , Philipps University of Marburg, Germany |
Targeting the tumor stroma: new concepts and potential approaches |
H-U. Simon |
Oct 12, 2022
|
12:15 |
Prof. Dr. Wolfgang Eberhardt, Pharmazentrum Frankfurt/ZAFES, Gothe University Frankfurt am Main |
Multifaceted roles of the E3 Ligase TRIM25 in colorectal cancer
|
A. Huwiler
|
Sept 21, 2022
|
12:15 |
Prof. Dr. med. Britta Maurer, Universitätsklinik für Rheumatologie und Immunologie, Inselspital, Bern |
Predictive potential of the integration of multi-source molecular data and imaging-based radiomic data in (experimental) fibrosing ILD
|
S. von Gunten
|
July 6, 2022
|
12:15 |
Priv. Doz. Dr. Gabriele Weitz-Schmidt, AlloCyte Pharmaceuticals AG, Basel |
Integrin targeting pharmacology - The mechanism of action matter |
A. Huwiler
|
| April 13, 2022 |
12:15 |
Dr. Michaela Medova, Department for BioMedical Research, University of Bern |
METworks - at the interface between radioresistance and behavior
|
G. Konstantinidou |
| Jan 19, 2022 |
12:15 |
Prof. Dr. Sebastian Leidel, Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern |
RNA modifications and disease: Cause or cure? |
A. Huwiler
|
